业界动态国内医卫资讯
NICE推荐PD-1抑制剂用于晚期肛门癌
Medscape News · 2026-11-12 23:13
摘要
NICE表示,英格兰约有250人可能受益于retifanlimab,该药现被推荐与化疗联合用于晚期肛门癌。Medscape News UK
English
NICE Recommends PD-1 Inhibitor for Advanced Anal Cancer
NICE said around 250 people in England could benefit from retifanlimab, now recommended with chemotherapy for advanced anal cancer. Medscape News UK